Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Views & Analysis
childhood epilepsy awareness

Taking on the challenge of childhood epilepsy

Japan’s Eisai has a long-term commitment to treating epilepsy, with a series of therapies already on the market - but with many different forms of the disease, requiring different therapeutic appro

Views & Analysis
Beautiful high school students with microscopes in laboratory during biology class.

Balancing the sySTEM

A group of pharma companies – Amgen, AstraZeneca and GlaxoSmithKline – have partnered with the UK government’s Equalities Office and Women’s Business Council to support small businesses in

Sales & Marketing

Digital

Market Access

Market Access
Mumbai, India

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Editor's Picks

  1. MSD, Moderna skin cancer vaccine scores historic phase 3 win
  2. Trump taps White House aide Heidi Overton to lead FDA
  3. Sandoz adds 10 biosimilars through $322m Henlius deal
  4. Claude Science outperforms experts in protein binder task
  5. Sanofi to lay off 229 Blueprint employees, close offices

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

more

Patients

more

R&D

more